147 related articles for article (PubMed ID: 29191603)
1. Serum lipid profile discriminates patients with early lung cancer from healthy controls.
Ros-Mazurczyk M; Jelonek K; Marczyk M; Binczyk F; Pietrowska M; Polanska J; Dziadziuszko R; Jassem J; Rzyman W; Widlak P
Lung Cancer; 2017 Oct; 112():69-74. PubMed ID: 29191603
[TBL] [Abstract][Full Text] [Related]
2. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
3. Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study.
Roś-Mazurczyk M; Wojakowska A; Marczak Ł; Polański K; Pietrowska M; Polanska J; Dziadziuszko R; Jassem J; Rzyman W; Widlak P
Acta Biochim Pol; 2017; 64(3):513-518. PubMed ID: 28803255
[TBL] [Abstract][Full Text] [Related]
4. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
5. Serum lipidome screening in patients with stage I non-small cell lung cancer.
Klupczynska A; Plewa S; Kasprzyk M; Dyszkiewicz W; Kokot ZJ; Matysiak J
Clin Exp Med; 2019 Nov; 19(4):505-513. PubMed ID: 31264112
[TBL] [Abstract][Full Text] [Related]
6. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.
Hocker JR; Peyton MD; Lerner MR; Mitchell SL; Lightfoot SA; Lander TJ; Bates-Albers LM; Vu NT; Hanas RJ; Kupiec TC; Brackett DJ; Hanas JS
Lung Cancer; 2011 Nov; 74(2):206-11. PubMed ID: 21529985
[TBL] [Abstract][Full Text] [Related]
7. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
8. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
[TBL] [Abstract][Full Text] [Related]
10. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum proteome components associated with progression of non-small cell lung cancer.
Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed Serum Biomarkers for the Detection of Lung Cancer.
Ma S; Wang W; Xia B; Zhang S; Yuan H; Jiang H; Meng W; Zheng X; Wang X
EBioMedicine; 2016 Sep; 11():210-218. PubMed ID: 27575387
[TBL] [Abstract][Full Text] [Related]
13. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
14. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
15. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
Pamungkas AD; Park C; Lee S; Jee SH; Park YH
Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
[TBL] [Abstract][Full Text] [Related]
16. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
17. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
19. The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea.
Kim HJ; Jang SH; Ryu JS; Lee JE; Kim YC; Lee MK; Jang TW; Lee SY; Nakamura H; Nishikata N; Mori M; Noguchi Y; Miyano H; Lee KY
Lung Cancer; 2015 Dec; 90(3):522-7. PubMed ID: 26476713
[TBL] [Abstract][Full Text] [Related]
20. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
